ScreenerHero

ENVB Enveric Biosciences, Inc.

NAS · US · Healthcare · Biotechnology · enveric.com
1.520USD+1.67%Mkt Cap: 6.80M $P/E: —

Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.47BUSDP/E 29.3
MRNA
Moderna, Inc.
$78.65BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.14BUSDP/E 18.3
ARGX
argenx SE
$51.48BUSDP/E 31.2
ARGX
argenx SE
$48.23BUSDP/E 31.4
UCB
UCB SA
$41.82BUSDP/E 17.8
RVMD
Revolution Medicines, Inc.
$40.32BUSD
ONC
BeOne Medicines AG
$39.83BUSDP/E 62.6
RPRX
Royalty Pharma plc
$32.48BUSDP/E 29.9
ALNY
Alnylam Pharmaceuticals, Inc.
$30.04BUSDP/E 37.9
ROIV
Roivant Sciences Ltd.
$24.71BUSD
BNTX
BioNTech SE
$23.13BUSD
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
GMAB
Genmab A/S
$22.17BUSDP/E 28.4
INSM
Insmed Incorporated
$21.94BUSD
GMAB
Genmab A/S
$21.10BUSDP/E 29.1
ASND
Ascendis Pharma A/S
$14.65BUSDP/E 17.1
EXEL
Exelixis, Inc.
$14.62BUSDP/E 18.6
JAZZ
Jazz Pharmaceuticals plc
$14.44BUSDP/E 15.2
SMMT
Summit Therapeutics Inc.
$13.70BUSD

Key Statistics

Company
Market Cap6.80M USD
Enterprise Value-1.72M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-8.77M USD
Revenue/Share—
Last Price1.520 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.04
PEG—
EV/EBITDA0.20
EV/Revenue—
P/S—
P/B0.72
EPS (TTM)-13.01
EPS (Forward)-1.41
52W Range
1.1703% of range13.25
52W High13.25 USD
52W Low1.170 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-209.98%
ROA-172.14%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.14M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-76.47%
Net Debt-8.30M USD
Net Debt/EBITDA0.97
Balance Sheet
Debt/Equity—
Current Ratio10.21
Quick Ratio9.63
Book Value/Sh2.05 USD
Cash/Share1.85 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 23, 2008
Pay DateNov 25, 2019
Splits
Last Split1:12
Split DateOct 28, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.48M
Float4.34M
Insiders8.89%
Institutions12.02%
Short Interest
Short Ratio0.2d
Short % Float0.52%
Short % Out.0.51%
Shares Short22.87K
Short (prev mo.)17.26K
Technical
SMA 501.473 (+3.2%)
SMA 2002.289 (-33.6%)
Beta1.18
S&P 52W Chg16.45%
Avg Vol (30d)72.64K
Avg Vol (10d)65.09K
Technical Indicators
RSI (14)53.6
MACD0.0068
MACD Signal0.0069
MACD Hist.-0.0001
BB Upper1.594 USD
BB Middle1.497 USD
BB Lower1.400 USD
BB Width12.97%
ATR (14)0.0908 USD
Vol Ratio (20d)1.06x